CoChat

Cannabis, Cannabinoids, and Stroke: Increased Risk or Potential for Protection—A Narrative Review

Open access
Carter, Caroline, Laviolette, Lindsay, Bietar, Bashir, Zhou, Juan, Lehmann, Christian · 2024 · Current Issues in Molecular Biology

The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.

Abstract

Worldwide, approximately 15 million people per year suffer from stroke. With about 5 million deaths, stroke is the second most common cause of death and a major cause of long-term disability. It is estimated that about 25% of people older than 85 years will develop stroke. Cannabis sativa and derived cannabinoids have been used for recreational and medical purposes for many centuries. However, due to the legal status in the past, research faced restrictions, and cannabis use was stigmatized for potential negative impacts on health. With the changes in legal status in many countries of the world, cannabis and cannabis-derived substances such as cannabinoids and terpenes have gained more interest in medical research. Several medical effects of cannabis have been scientifically proven, and potential risks identified. In the context of stroke, the role of cannabis is controversial. The negative impact of cannabis use on stroke has been reported through case reports and population-based studies. However, potential beneficial effects of specific cannabinoids are described in animal studies under certain conditions. In this narrative review, the existing body of evidence regarding the negative and positive impacts of cannabis use prior to stroke will be critically appraised.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cimb46040196

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mechanisms of cannabis-induced angiopathy leading to ischemia.
Figure 1 Mechanisms of cannabis-induced angiopathy leading to ischemia.CC BY · PubMed Central
Figure 2 Mechanisms of action for neuroprotection by CB1 and/or CB2 receptor activation. Information from [49,63,67,68,69].
Figure 2 Mechanisms of action for neuroprotection by CB1 and/or CB2 receptor activation. Information from [49,63,67,68,69].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 84 references

Research works printed but not linked: 1

  1. Amin, M.R., and Ali, D.W. (2019). Recent Advances in Cannabinoid Physiology and Pathology, Springer.

Cited by

See all 13

Metadata

Authors
Carter, C., Laviolette, L., Bietar, B., Zhou, J., & Lehmann, C.
Affiliations
  • Dalhousie University (CA)
  • Department of Anesthesia, Dalhousie University, Halifax, NS B3H 4R2, Canada
Corresponding author
Carter, Caroline
Venue
Current Issues in Molecular Biology
Publisher
MDPI AG
Published
2024-04-04
Volume
46
Issue
4
Pages
3122-3133
ISSN
  • 1467-3037 (ISSN-L)
  • 1467-3045
OpenAlex
W4393949197
Cited by
13
References
84
Citations by year
2026: 6 · 2025: 5 · 2024: 2
FWCI
0.75
Type
journal article
Language
en
Open access
Locations
  • Current Issues in Molecular Biology (publishedVersion, cc-by)
  • Preprints.org (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords
cannabis, cannabinoids, stroke, Cannabis sativa, terpenes, stroke risk, neuroprotection, medical cannabis, recreational cannabis use, cannabis legalization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cannabis, Cannabinoids, and Stroke: Increased Risk or Potential for Protection—A Narrative Review. https://app.cochat.ai/papers/10.3390/cimb46040196
The paper
Carter, C., Laviolette, L., Bietar, B., Zhou, J., & Lehmann, C. (2024). Cannabis, Cannabinoids, and Stroke: Increased Risk or Potential for Protection—A Narrative Review. Current Issues in Molecular Biology. https://doi.org/10.3390/cimb46040196

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.